These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 349931

  • 1. [Combination hemodilution and defibrinogenating therapy in chronic arterial occlusive diseases].
    Ehrly AM, Saeger-Lorenz K.
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():332-3. PubMed ID: 349931
    [No Abstract] [Full Text] [Related]

  • 2. [Hemorheologic and clinical in vitro and in vivo studies of the effectiveness of isovolemic hemodilution using Gelafusal and Infukoll M40 in patients with peripheral arterial occlusive disease].
    Pöhlmann G, Braumann A, Grohmann G.
    Vasa Suppl; 1991; 32():342-4. PubMed ID: 1722914
    [No Abstract] [Full Text] [Related]

  • 3. Improvement of the flow properties of blood: a new therapeutical approach in occlusive arterial disease.
    Ehrly AM.
    Angiology; 1976 Mar; 27(3):188-96. PubMed ID: 1078314
    [Abstract] [Full Text] [Related]

  • 4. [Results of treatment with ancrod (Arwin) in 21 patients with chronic arterial occlusive disease].
    Rosendo A, Sala Planell E, Latorre J, Marinello J, Olba L, Rutllant ML.
    Rev Clin Esp; 1982 Mar 15; 164(5):313-6. PubMed ID: 7100546
    [No Abstract] [Full Text] [Related]

  • 5. [Hemorheologic effects of hydroxyethyl starch 200/0.5, dextran 40, oxypolygelatine and full electrolyte solution over 48 hours].
    Brehme S, Keysser G, Turowski A, Schmidt HH.
    Z Gesamte Inn Med; 1993 Oct 15; 48(10):506-10. PubMed ID: 7504854
    [Abstract] [Full Text] [Related]

  • 6. [Therapy of chronic peripheral arterial occlusive diseases with snake venom enzyme Arwin].
    Ehrly AM.
    Med Welt; 1975 Mar 07; 26(10):446-55. PubMed ID: 1123988
    [No Abstract] [Full Text] [Related]

  • 7. [Drug-induced improvement of blood flow properties. Effective principle in the treatment of arterial occlusive diseases].
    Hess H, Franke I, Jauch M.
    Fortschr Med; 1973 Jun 14; 91(17):743-8. PubMed ID: 4577522
    [No Abstract] [Full Text] [Related]

  • 8. [Therapeutic defibrinogenation as conservative therapy of peripheral arterial occlusive disease. A critical analysis].
    Ernst E.
    MMW Munch Med Wochenschr; 1983 Sep 16; 125(37):796-8. PubMed ID: 6415441
    [No Abstract] [Full Text] [Related]

  • 9. [Rheologic effects of normovolemic hemodilution].
    Kuznetsov NA, Aleksandrova NP, Bogdanov AE, Rogulenko RV.
    Anesteziol Reanimatol; 1990 Sep 16; (2):18-22. PubMed ID: 1698041
    [Abstract] [Full Text] [Related]

  • 10. [Therapeutic lowering of fibrinogen levels].
    Ernst E.
    MMW Munch Med Wochenschr; 1983 May 27; 125(21):83-4. PubMed ID: 6410202
    [No Abstract] [Full Text] [Related]

  • 11. Arwin in peripheral arterial circulatory disorders: controlled multicentre trials.
    Wolf GK.
    Eur J Clin Pharmacol; 1976 Mar 22; 09(5-6):387-92. PubMed ID: 786664
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Proceedings: Clinical improvement in peripheral circulation by controlled defibrinogenation.
    Dormandy JA, Goyle KB.
    Br J Surg; 1976 Aug 22; 63(8):661-2. PubMed ID: 953495
    [No Abstract] [Full Text] [Related]

  • 14. Hemodilution combined with defibrinogenation.
    Böhme H, Everts B.
    Bibl Haematol; 1981 Aug 22; (47):165-72. PubMed ID: 7039611
    [No Abstract] [Full Text] [Related]

  • 15. Hypervolumetric hemodilution with HES 100/0.5 10% in patients with peripheral arterial occlusive disease (Fontaine, stage II): an open clinical and pharmacological phase IV study.
    Koscielny J, Latza R, Pruss A, Kiesewetter H, Jung F, Meier C, Schimetta W.
    Clin Hemorheol Microcirc; 2000 Aug 22; 22(1):53-65. PubMed ID: 10711822
    [Abstract] [Full Text] [Related]

  • 16. [Hemodilution in peripheral arterial occlusive disease. Placebo controlled randomized double-blind study with hydroxyethyl starch or dextran].
    Ernst E, Kollar L, Matrai A.
    Acta Med Austriaca; 1991 Aug 22; 18 Suppl 1():27-9. PubMed ID: 1719730
    [Abstract] [Full Text] [Related]

  • 17. [Defibrination with the snake venom enzyme arwin in peripheral arterial obstructive disease. Possibilities and limitations (author's transl)].
    Böhme H, Schmidt P, Hüttel E.
    MMW Munch Med Wochenschr; 1978 Nov 10; 120(45):1501-4. PubMed ID: 101819
    [Abstract] [Full Text] [Related]

  • 18. [A comparative study of the effects of hemodilution with dextran and fluorocarbon emulsion on the changes in blood viscosity and collateral flow during myocardial ischemia].
    Ma XL, Zhao RR, Zang YM, Wang FZ.
    Yao Xue Xue Bao; 1987 Sep 10; 22(9):641-4. PubMed ID: 2451396
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Blood flow properties and walking performance in chronic arterial occlusive disease.
    Angelkort B, Spürk P, Habbaba A, Mähder M.
    Angiology; 1985 May 10; 36(5):285-92. PubMed ID: 3896044
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.